BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4372170)

  • 1. Stimulation of peripheral blood lymphocytes by herpes simplex virus in vitro.
    Scriba M
    Infect Immun; 1974 Sep; 10(3):430-6. PubMed ID: 4372170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral and cellular immune responses to an envelope-associated antigen of herpes simplex virus.
    Zaia JA; Palmer EL; Feorino PM
    J Infect Dis; 1975 Dec; 132(6):660-6. PubMed ID: 172562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of cellular immunity to herpes simplex virus: relationship to the humoral immune response.
    Rosenberg GL; Notkins AL
    J Immunol; 1974 Mar; 112(3):1019-25. PubMed ID: 4359780
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro stimulation of sensitized lymphocytes by herpes simplex virus and vaccinia virus.
    Rosenberg GL; Farber PA; Notkins AL
    Proc Natl Acad Sci U S A; 1972 Mar; 69(3):756-60. PubMed ID: 4335071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of human lymphocytes by Herpes simplex virus antigens.
    Starr SE; Karatela SA; Shore SL; Duffey A; Nahmias AJ
    Infect Immun; 1975 Jan; 11(1):109-12. PubMed ID: 163788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of chemotactic factor and lymphotoxin by human leukocytes stimulated with Herpes simplex virus.
    Rosenberg GL; Snyderman R; Notkins AL
    Infect Immun; 1974 Jul; 10(1):111-5. PubMed ID: 4366917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction and in Vitro demonstration of cellular immunity to DNA and RNA viruses in guinea-pigs.
    Koszinowski U; Bandlow G
    Clin Exp Immunol; 1975 Apr; 20(1):143-54. PubMed ID: 173485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte interferon production and transformation after Herpes simplex infections in humans.
    Rasmussen LE; Jordan GW; Stevens DA; Merigan TC
    J Immunol; 1974 Feb; 112(2):728-36. PubMed ID: 4360547
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulation of expression of herpes simplex virus (HSV) glycoprotein D in vaccinia recombinants affects their ability to protect from cutaneous HSV-2 disease.
    Wachsman M; Aurelian L; Smith CC; Perkus ME; Paoletti E
    J Infect Dis; 1989 Apr; 159(4):625-34. PubMed ID: 2538519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of antibody in in vitro stimulation of lymphocytes.
    Kapoor AK; Khan IU; Bhushan V
    Indian J Exp Biol; 1983 Nov; 21(11):583-4. PubMed ID: 6327508
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell-mediated immunity to Herpes simplex in humans: lymphocyte cytotoxicity measured by 51-Cr release from infected cells.
    Russell AS; Percy JS; Kovithavongs T
    Infect Immun; 1975 Feb; 11(2):355-9. PubMed ID: 163220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of interferon by immune lymphocytes exposed to herpes simplex virus-antibody complexes.
    Fujibayashi T; Hooks JJ; Notkins AL
    J Immunol; 1975 Nov; 115(5):1191-3. PubMed ID: 170341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the humoral and cellular immune response after immunization with live, UV inactivated herpes simplex virus and a subunit vaccine and efficacy of these immunizations.
    Cappel R
    Arch Virol; 1976; 52(1-2):29-35. PubMed ID: 187150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host defense mechanisms against infectious bovine rhinotracheitis virus: in vitro stimulation of sensitized lymphocytes by virus antigen.
    Rouse BT; Babiuk LA
    Infect Immun; 1974 Oct; 10(4):681-7. PubMed ID: 4426702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune specific production of interferon by human T cells in combined macrophage-lymphocyte cultures in response to Herpes simplex antigen.
    Valle MJ; Bobrove AM; Strober S; Merigan TC
    J Immunol; 1975 Jan; 114(1 Pt 2):435-41. PubMed ID: 46881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent cellular protection against herpes simplex virus dissemination as revealed by viral plauqe and infectivity assays.
    Shimizu F; Hanaumi K; Shimizu Y; Kumagai K
    Infect Immun; 1977 May; 16(2):531-6. PubMed ID: 193792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral and cell-mediated immunity in neonates with herpes simplex virus infection.
    Sullender WM; Miller JL; Yasukawa LL; Bradley JS; Black SB; Yeager AS; Arvin AM
    J Infect Dis; 1987 Jan; 155(1):28-37. PubMed ID: 3025306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of herpes simplex virus antibody titers and specific lymphocyte stimulation in adult blood donors.
    Moser H; Behrens F; Ziegelmaier R; Hilfenhaus J; Mauler R
    J Clin Microbiol; 1981 Jan; 13(1):36-41. PubMed ID: 6257756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of herpes simplex antisera with increased type specificity in guinea pigs by antibody suppression.
    Jeansson S; Ericsson H
    Proc Soc Exp Biol Med; 1974 Dec; 147(3):788-94. PubMed ID: 4374703
    [No Abstract]   [Full Text] [Related]  

  • 20. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.